Get started
AlenCiken

granted EU Orphan Drug Designation for Rintatolimod

AIM ImmunoTech Inc. (AMEX:AIM)  
AlenCiken  
AMEX:AIM   AIM ImmunoTech Inc.
Trend Analysis Chart Patterns Fundamental Analysis biotech biotechnology biotechstocks biotechs biotechstock biotehnology stockstotrade stockstowatch
4
0
trendanalysis chartpattern fundamental biotech biotechnology biotechstocks biotechs biotechstock biotehnology stockstotrade stockstowatch
JUST GOT POSITIVE EU RECOMMENDATION

$AIM (old $HEB) granted EU Orphan Drug Designation for Rintatolimod for treatment of pancreatic cancer, Hemispherx Biopharma Europe.

Rintatolimod is Ampligen

This is going to trap shorts and when they PR this is going to explode!

www.ema.europa.eu/en...-january-2021_en.pdf

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.